SCM
CCCC icon

Silverarc Capital Management’s C4 Therapeutics CCCC Stock Holding History

Silverarc Capital Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.03M Sell
1,911,785
-82,439
-4% -$194K 0.51% 43
2025
Q4 		$3.81M Buy
1,994,224
+96,841
+5% +$229K 0.53% 45
2025
Q3 		$4.21M Buy
+1,897,383
New +$4.55M 0.57% 46
2025
Q2 		– Sell
-882,300
Closed -$1.41M – 71
2025
Q1 		$1.41M Sell
882,300
-338,831
-28% -$1.01M 0.29% 54
2024
Q4 		$4.4M Buy
1,221,131
+73,240
+6% +$364K 0.96% 34
2024
Q3 		$6.54M Sell
1,147,891
-294,950
-20% -$1.78M 1.47% 22
2024
Q2 		$6.67M Buy
1,442,841
+6,910
+0.5% +$41.2K 1.57% 20
2024
Q1 		$11.7M Buy
+1,435,931
New +$11.1M 3.26% 9

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return